Full Service

Neoclinus leverages software intelligence combined with clinical expertise to optimize the conduct and reporting of clinical trials, regardless of complexity. This approach ensures robust and effective communication across teams at the company, site, and sponsor levels.

Neoclinus has extensive experience collaborating with CROs, vendors, and study teams to support clinical, safety, and marketing programs. These partnerships enable Neoclinus to offer a full-service CRO approach, with employees experienced across various therapeutic areas and all phases of clinical trials, including Phase I, Phase II/III, and Phase IV/post-marketing studies. Our visualization technology facilitates easy access to data from multiple studies and programs, enhancing data utilization and decision-making.

Non-Interventional Studies:

Non-Interventional studies (NIS) are the core source of clinical information for vast number of patients’ populations and important element in the integration of clinical development. Non Interventional studies cover the following categories:

• Patient Registry
• Disease Registry
• Post-Marketing Surveillance studies
• Epidemiological studies
• case control studies
• cohort studies
• Post Authorization Safety studies (PASS)
• Investigator Initiated Trials (IIT)
• Pharmacoeconomic studies
• Observational studies

Interventional Studies (PhaseI-IV) :

With the completion of a significant number of projects, covering a broad range of therapeutic areas, we offer a portfolio of proven experience in Interventional Studies. Our well trained professionals are readily available to meet project needs and provide solutions, advice and local expertise.